CY2458B1 - Novel benzofuran-4-carboxamides. - Google Patents

Novel benzofuran-4-carboxamides.

Info

Publication number
CY2458B1
CY2458B1 CY0400046A CY0400046A CY2458B1 CY 2458 B1 CY2458 B1 CY 2458B1 CY 0400046 A CY0400046 A CY 0400046A CY 0400046 A CY0400046 A CY 0400046A CY 2458 B1 CY2458 B1 CY 2458B1
Authority
CY
Cyprus
Prior art keywords
carboxamides
novel benzofuran
benzofuran
novel
substituted
Prior art date
Application number
CY0400046A
Other languages
English (en)
Inventor
Wolf-Ruediger Ulrich
Dieter Flockerzi
Beate Degutterer
Ulrich Thibaut
Armin Hatzelmann
Christian Schudt
Dietrich Haefner
Hans-Peter Kley
Hermann Amschler
Rolf Beume
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of CY2458B1 publication Critical patent/CY2458B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Table Devices Or Equipment (AREA)
  • Furan Compounds (AREA)
CY0400046A 1996-08-19 2004-06-08 Novel benzofuran-4-carboxamides. CY2458B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19633052 1996-08-19

Publications (1)

Publication Number Publication Date
CY2458B1 true CY2458B1 (en) 2005-06-03

Family

ID=7802799

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0400046A CY2458B1 (en) 1996-08-19 2004-06-08 Novel benzofuran-4-carboxamides.

Country Status (11)

Country Link
US (1) US6211203B1 (de)
EP (1) EP0923568B9 (de)
JP (1) JP4309475B2 (de)
AT (1) ATE229516T1 (de)
AU (1) AU4454597A (de)
CY (1) CY2458B1 (de)
DE (1) DE69717827T2 (de)
DK (1) DK0923568T5 (de)
ES (1) ES2188983T4 (de)
PT (1) PT923568E (de)
WO (1) WO1998007715A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126558A (en) * 1996-05-20 2002-07-25 Darwin Discovery Ltd Benzofuran carboxamides and pharmaceutical compositions containing them
CN1290266A (zh) * 1998-02-09 2001-04-04 达尔文发现有限公司 苯并呋喃－4－甲酰胺和其治疗用途
TW555759B (en) * 1998-06-08 2003-10-01 Darwin Discovery Ltd Heterocyclic compounds and their therapeutic use
ATE245642T1 (de) 1998-06-10 2003-08-15 Altana Pharma Ag Benzamide mit tetrahydrofuranyloxy-substituenten als inhibitoren der phosphodiesterase 4
JP2002529444A (ja) * 1998-11-12 2002-09-10 アリアド・ファーマシューティカルズ・インコーポレイテッド 二環式シグナル伝達阻害剤、それを含む組成物とその用途
DE19924340A1 (de) 1999-05-27 2000-11-30 Basf Ag Verfahren zur selektiven Hydrierung von ethylenisch ungesättigten Doppelbindungen in Polymeren
CA2381802C (en) 1999-08-21 2010-12-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of roflumilast and salmeterol
GB0003257D0 (en) 2000-02-11 2000-04-05 Darwin Discovery Ltd Heterocyclic compounds and their therapeutic use
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
EP1940389A2 (de) 2005-10-21 2008-07-09 Braincells, Inc. Modulation von neurogenese durch pde-hemmung
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7842713B2 (en) * 2006-04-20 2010-11-30 Pfizer Inc Fused phenyl amido heterocyclic compounds
EP2021000A2 (de) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenese mittels angiotensin-modulation
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
EP2068872A1 (de) 2006-09-08 2009-06-17 Braincells, Inc. Kombinationen mit einem 4-acylaminopyridin-derivat
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
NZ591366A (en) 2008-09-11 2012-05-25 Pfizer Heteroaryls amide derivatives and their use as glucokinase activators
AR074760A1 (es) * 2008-12-18 2011-02-09 Metabolex Inc Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
SI2406253T1 (sl) 2009-03-11 2013-09-30 Pfizer Inc. Derivati benzofuranila, uporabljeni kot inhibitorji glukokinaze
RU2446143C2 (ru) * 2010-05-19 2012-03-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославский государственный технический университет" (ЯГТУ) Способ получения эфиров замещенных 5,6-дицианобензофуран-2-карбоновых кислот
US8299117B2 (en) 2010-06-16 2012-10-30 Metabolex Inc. GPR120 receptor agonists and uses thereof
ES2526124T3 (es) * 2010-06-16 2015-01-07 Cymabay Therapeutics, Inc. Agonistas del receptor GPR120 y sus usos
EP2804603A1 (de) 2012-01-10 2014-11-26 President and Fellows of Harvard College Betazellen-replikation für promoterverbindungen und verwendungsverfahren dafür
CN111094279B (zh) * 2017-11-10 2023-06-16 江苏恒瑞医药股份有限公司 一种苯并呋喃衍生物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0706513B1 (de) * 1993-07-02 2002-05-15 Byk Gulden Lomberg Chemische Fabrik GmbH Fluoralkoxy substituierte benzamide und ihre verwendung als zyklisch-nukleotid phosphodiesterase-inhibitoren
MX9700557A (es) * 1994-07-22 1997-12-31 Byk Gulden Lomberg Chem Fab Dihidrobenzofuranos.
EP0771794B1 (de) * 1995-05-19 2006-05-03 Kyowa Hakko Kogyo Co., Ltd. Sauerstoff enthaltende heterocyclische verbindungen
JP2000501411A (ja) * 1995-12-05 2000-02-08 ダーウィン・ディスカバリー・リミテッド ベンゾフランカルボキサミドおよびスルホンアミド
IL126558A (en) * 1996-05-20 2002-07-25 Darwin Discovery Ltd Benzofuran carboxamides and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ES2188983T4 (es) 2004-06-01
US6211203B1 (en) 2001-04-03
EP0923568B1 (de) 2002-12-11
DE69717827T2 (de) 2003-09-04
JP4309475B2 (ja) 2009-08-05
WO1998007715A9 (de) 1999-04-29
DK0923568T3 (da) 2003-04-07
DE69717827D1 (de) 2003-01-23
DK0923568T5 (da) 2003-11-03
AU4454597A (en) 1998-03-06
EP0923568B9 (de) 2003-08-13
ATE229516T1 (de) 2002-12-15
WO1998007715A1 (de) 1998-02-26
JP2000516932A (ja) 2000-12-19
ES2188983T3 (es) 2003-07-01
EP0923568A1 (de) 1999-06-23
PT923568E (pt) 2003-04-30

Similar Documents

Publication Publication Date Title
CY2458B1 (en) Novel benzofuran-4-carboxamides.
EA199700061A1 (ru) Способ получения силденафила
AU6613896A (en) Chemical compounds
ZA955274B (en) Compound for and method of inhibiting phosphodiesterase IV
ES2193252T3 (es) Quinolonas y su uso terapeutico.
ZA9610315B (en) Naphthyl-substituted benzimidazole derivates as anti-coagulants
MY111201A (en) New imidazopyridines
DE69722656D1 (de) Bicyclische arylcarboxamide und ihre therapeutische verwendung
EP0700291A4 (de) In 15-stellung substituierte 4-azasteroide
AU5320698A (en) Substituted dihydrobenzofurans as pde inhibitors
GB9606417D0 (en) Asymmetric cyclisation
IL127574A0 (en) Inhibitors of prenyl transferases
ZA964010B (en) Use of pyrrole compounds as antifouling agents.
ZA9410023B (en) Herbicides
PL311279A1 (en) Herbicidal substituted 1-phenyl or 1-pyridinyl benzotriazoles
ZA9419B (en) Preparation process for sulphurated derivatives of imidazole and the new intermediates obtained.
GR1002598B (el) Παραγωγα επι-επιβατιδινης.
BG103834A (en) Chemical method for the reduction of 1-substituted-3-hydroxymethyl-4-(4-fluorophenyl)tetrahydropyridine s ines
PL314491A1 (en) Herbicidal pyrrole pyridines
MX9500228A (es) N-oxidos de 4-arilpiperazinas y 4-arilpiperidinas.
NZ333854A (en) Intermediates for the preparation of 2-imidazoline-5-ones
IL107242A0 (en) Derivatives of benzeneborinic acid, preparation thereof and use thereof as synthetic intermediates
PH31255A (en) Use of triazine compounds as anxiolytics.
BG101236A (en) Herbicidal composition
ES8307251A1 (es) Un procedimiento para la preparacion de derivados de acido clavulanico.